Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,485 across all filing types
Latest filing 2018-05-23 Director's Dealing
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Insider's tradings
Director's Dealing Classification · 100% confidence The document is a notification of a transaction in Coloplast A/S shares by a member of the senior management (CFO & Executive Vice President, Anders Lonning-Skovgaard). It explicitly references the Market Abuse Regulation (Markedsmisbrugsforordringen) regarding the reporting of transactions by persons discharging managerial responsibilities. This fits the definition of a Director's Dealing (DIRS) filing.
2018-05-23 Danish
Transaction in Own Shares 2018
Transaction in Own Shares Classification · 100% confidence The document explicitly details transactions executed under a 'Share buy-back programme' over a specific period (14 – 18 May 2018), including the number of shares bought and the total amount spent. This activity directly corresponds to the company purchasing its own shares. According to the definitions, 'Transaction in Own Shares (Code: POS)' covers 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. Although it is an announcement, the core content is the transaction data itself, making POS a more specific fit than the general RPA or RNS.
2018-05-22 English
Transaction in Own Shares 2018
Transaction in Own Shares Classification · 100% confidence The document title explicitly states: "Transaction data in relation to Coloplast's share buy-back programme, week 20 22 May 2018". The content details specific transactions (buying shares) executed over a period (14 – 18 May 2018) under a share buy-back program, referencing EU regulation (EU) 2016/1052. This directly corresponds to the definition of a filing reporting the company buying back or selling its own shares, which is classified as 'Transaction in Own Shares' (POS).
2018-05-22 English
Share buy-back week 20/2018
Transaction in Own Shares Classification · 100% confidence The document contains detailed transactional data related to Coloplast's share buyback program for a specific week in May 2018. It includes dates, number of shares repurchased, prices, and total amounts spent, along with compliance references to EU regulations on share buybacks. The content is focused on the company's repurchase of its own shares, with no financial statements, earnings data, or management commentary. The document is not an announcement of a report but a detailed transactional disclosure. Therefore, it fits the category of a report on the company's transactions in its own shares (share repurchase program).
2018-05-22 English
Share buy-back week 20/2018
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from Coloplast detailing specific transactions made under their share buyback program (aktietilbagekøbsprogram). It lists the number of shares purchased, the purchase price, and the total amount spent over a specific period (May 14-18, 2018), citing compliance with EU Market Abuse Regulation (MAR). This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2018-05-22 Danish
Share buy-back week 20/2018
Transaction in Own Shares Classification · 100% confidence The document is a corporate announcement regarding the company's share buyback program (Aktietilbagekøb). It details specific transactions (number of shares, price, and total value) conducted by Coloplast during week 20 of 2018. This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2018-05-22 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.